NASDAQ: NRC - National Research Corporation

Lønnsomhet i seks måneder: -44.58%
Utbytte: +2.93%
Sektor: Healthcare

Kampanjeplan National Research Corporation


Om selskapet National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

flere detaljer
The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

IPO date 1997-10-10
ISIN US6373722023
Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 4.68
Дивиденд ао 0.12
Сайт https://www.nrchealth.com
Цена ао 13.94
Prisendring per dag: 0% (10.78)
Prisendring per uke: -9.87% (11.96)
Prisendring per måned: -27.31% (14.83)
Prisendring over 3 måneder: -36.33% (16.93)
Prisendring over seks måneder: -44.58% (19.45)
Prisendring per år: -68.63% (34.36)
Prisendring over 3 år: -72.62% (39.37)
Prisendring over 5 år: -69.21% (35.01)
Prisendring siden begynnelsen av året: -39.4% (17.79)

Undervurdering

Navn Betydning Karakter
P/S 2.89 6
P/BV 13.21 1
P/E 16.68 7
EV/EBITDA 11.42 7
Total: 6.25

Effektivitet

Navn Betydning Karakter
ROA, % 19.44 6
ROE, % 61.77 10
Total: 6.5

Utbytte

Navn Betydning Karakter
Div yield, % 2.93 7.33
DSI 0.8571 8.57
Total: 5.93

Plikt

Navn Betydning Karakter
Debt/EBITDA 1.52 7
Total: 6.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 7.32 1
Lønnsomhet Ebitda, % -17.88 0
Lønnsomhet EPS, % -28.01 0
Total: 0.2

ETFDele, %Lønnsomhet for året, %Utbytte, %
iShares Morningstar Small-Cap Growth ETF 0.01365 596.94 0.72598
iShares Morningstar Small-Cap ETF 0.00669 391.25 1.60498
0.01494.11.17



Veileder Stillingstittel Betaling Fødselsår
Mr. Michael D. Hays Founder, CEO, President & Director 131.11k 1955 (70 år)
Ms. Helen L. Hrdy Chief Customer Officer 291.51k 1965 (60 år)
Mr. Jon Boumstein Chief Delivery Officer N/A
Megan Charko Senior Manager of Content Marketing N/A
Mr. Christophe Louvion Chief Product & Technology Officer N/A 1973 (52 år)
Mr. Andy Monnich Chief Corporate Development Officer N/A 1976 (49 år)
Mr. Jason Hahn Chief Revenue Officer N/A 1972 (53 år)
Ms. Linda Stacy Secretary N/A
Ms. Vinitha Ramnathan Chief Product Officer

Adresse: United States, Lincoln. NE, 1245 Q Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.nrchealth.com